Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV - a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
TL;DR
- FDA approves generic version of HIV prevention shot.
- This is the world's only twice-a-year HIV prevention shot.
- Goal is inexpensive and quicker availability in 120 low- and middle-income countries.